DCF — JOHNSON CITY MEDICAL CENTER
Enterprise Value: $-754.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-754.5M
Enterprise Value
$-241.7M
PV of Cash Flows
$-512.7M
PV of Terminal Value
$-825.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $562.5M | $-45.3M | -8.0% | $-69.2M | $-62.9M |
| Year 2 | $579.4M | $-40.9M | -7.0% | $-65.4M | $-54.1M |
| Year 3 | $596.7M | $-36.2M | -6.0% | $-61.4M | $-46.2M |
| Year 4 | $614.6M | $-34.2M | -6.0% | $-60.2M | $-41.1M |
| Year 5 | $633.1M | $-33.6M | -5.0% | $-60.4M | $-37.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-754.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$546.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.08560969136157535
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5